Galantamine for Cognition in People With Schizophrenia

Completed · Phase 4

Conditions studied: Schizophrenia, Schizoaffective Disorder

In brief

This study is a double-blind, placebo-controlled trial of the nicotinic receptor agonist, galantamine, for the improvement of memory and attention in people with schizophrenia and schizoaffective disorder. Twenty subjects on a stable dose of antipsychotic medications receive galantamine or identical placebo tablets for 8 weeks. Adverse events are screened for every week. Tests of memory, attention, and reward responsivity are performed at baseline and afer 8 weeks on medication. Clinical scales rating psychiatric symptoms are performed at the beginning, middle, and end of the trial.

Key facts

Study ID

NCT00320736

Run by

North Suffolk Mental Health Association

People needed

20

Starts

2004-01-01

Expected to finish

2006-05-01

Last updated by the study team

2009-05-19

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of schizophrenia or schizoaffective disorder depressed type with stable psychiatric symptoms, no active suicidal ideation
• Age 18-60, inclusive
• Stable medical conditions such as hypertension, non-insulin-dependent diabetes, hypothyroidism allowed
• Treated with antipsychotic medications at a stable dose for > 4 weeks
• Not treated with investigational medications in the past 30 days
• Competent to provide informed consent
• WRAT-3 IQ raw score greater than or equal to 35
• Expired CO level < 9 ppm
• Salivary cotinine level < 30 ng/ml
• Non-smoker for at least 3 months

You may not qualify if…

• Diagnosis of dementia, neurodegenerative disease or any other current Axis I DSM-IV diagnosis
• Any unstable medical illness, asthma requiring daily treatment, severe COPD, active peptic ulcer disease, gastrointestinal bleeding, atrioventricular block, urinary outflow obstruction, history of epilepsy
• Concurrent use of anticholinergic medications or use of cholinomimetic medications in the past month, such as cogentin, donepezil or clozapine
• Alcohol or substance abuse in the past month (self-report and confirmed by chart)
• Known allergy or hypersensitivity to galantamine
• Current treatment with erythromycin or ketoconazole
• Concurrent use of NSAIDs
• Women of childbearing potential
• History of suicide attempt in the past year

Where it is running

• Freedom Trail Clinic — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.